Actively Recruiting
Evaluating Intravenous Tranexamic Acid to Reduce Bleeding During Transurethral Resection of the Prostate Surgery A Randomized, Quadruple-Blind, Placebo-Controlled Trial
Led by Hamza Najout · Updated on 2026-10-09
80
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research aims to assess whether giving intravenous tranexamic acid around the time of surgery reduces blood loss and maintains blood hemoglobin levels in men aged 50 and older undergoing transurethral resection of the prostate TURP under spinal anesthesia. The trial is a prospective, randomized, quadruple-blind, placebo-controlled study designed to evaluate perioperative bleeding and recovery in patients with benign prostatic hyperplasia. Participants are randomly assigned to receive either tranexamic acid at a dose of 10 mgkg or a matching placebo intravenously about 30 minutes before TURP surgery. The study compares blood loss during surgery measured by hemoglobin in irrigation fluid and hemoglobin levels 24 hours after surgery. Secondary outcomes include transfusion needs, surgery duration, catheterization length, hospital stay, adverse events, and economic impacts. During the trial, participants will undergo standardized spinal anesthesia and receive the assigned treatment before surgery. Researchers will monitor blood loss during the operation and measure hemoglobin levels afterward. Follow-up includes tracking recovery markers, transfusions, urinary catheter duration, hospital length of stay, and any complications up to 30 days post-surgery. The study duration encompasses surgery and hospital discharge monitoring, with data collection for safety and health-economic evaluation.
CONDITIONS
Brief Title
Tranexamic Acid for Bleeding Reduction During TURP Surgery
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here